Table 1. Summary of patient demographics and clinical characteristics.
| Characteristic | Training cohort | Internal testing cohort | GSE14520 testing cohort | ICGC testing cohort | Entire testing cohort |
|---|---|---|---|---|---|
| Gender | |||||
| Male | 246 (67%) | 121 (66%) | 191 (87%) | 182 (75%) | 619 (75%) |
| Female | 119 (33%) | 63 (34%) | 29 (13%) | 61 (25%) | 209 (25%) |
| Age | |||||
| <60 | 165 (45%) | 83 (45%) | 177 (80%) | 45 (18%) | 387 (47%) |
| >=60 | 200 (55%) | 101 (55%) | 43 (20%) | 198 (82%) | 441 (53%) |
| Stage | |||||
| Stage I–II | 254 (74%) | 136 (78%) | 170 (77%) | 146 (60%) | 570 (70%) |
| Stage III–IV | 88 (26%) | 38 (22%) | 50 (23%) | 97 (40%) | 235 (30%) |
| Vital status | |||||
| Living | 239 (65%) | 125 (68%) | 135 (61%) | 199 (82%) | 573 (69%) |
| Dead | 126 (35%) | 59 (32%) | 85 (39%) | 45 (18%) | 255 (31%) |